CLINICAL_TRIALS
trial_result
· 2018-06-28
Clinical Trial Update: A Study of Varlitinib in Japanese Subjects With Advanced or Metastatic Solid Tumours [Phase 1]
Summary
Phase 1 study of varlitinib in Japanese patients with advanced or metastatic solid tumors, including biliary tract cancer, has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: ASLAN Pharmaceuticals | Conditions: Advanced or Metastatic Biliary Tract Cancer, Advanced or Metastatic Solid Tumors | Phase 1 | Status: COMPLETED